Madison Avenue Partners »

Mirati Therapeutics shares owned by Madison Avenue Partners

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Madison Avenue Partners from 13F filings

Historical chart of Madison Avenue Partners investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Madison Avenue Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Madison Avenue Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 417k 58.75

More positions owned by Madison Avenue Partners

Sharkninja Com Shs (SN)
Graham Hldgs Com Cl B (GHC)
Theravance Biopharma (TBPH)
Stagwell Com Cl A (STGW)
Integra Lifesciences Hlds C Com New (IART)
G-III Apparel (GIII)
Hess (HES)
Vestis Corporation Com Shs (VSTS)
Mirati Therapeutics
Orion Office Reit Inc-w/i (ONL)
Ovid Therapeutics (OVID)
Franklin Street Properties (FSP)
2seventy Bio Common Stock (TSVT)
Merrimack Pharmaceuticals Com New (MACK)
Gossamer Bio (GOSS)

View all positions for Madison Avenue Partners

Top funds holding Mirati Therapeutics

venBio Select Advisor
Sawtooth Asset Management
Hsbc Holdings
Alliancebernstein
National Bank Of Canada /fi/
Madison Avenue Partners
Healthcare Of Ontario Pension Plan Trust Fund
Sand Grove Capital Management
Bank of Nova Scotia
Alberta Investment Management Corporation
Kellner Capital
Guggenheim Capital, LLC Managers
Algert Coldiron Investors
IFP Advisors
Federated Investors

View all funds holding Mirati Therapeutics